TGFB1 and Hepatic fibrosis: This could be because the current participants at baseline did not have fibrosis, and even though the group that did not show improvement in IFC after a 2-year period did increase liver fibrosis, the values remained within the non-pathological stage, potentially explaining the lack of significant changes in TGF-β1 plasma levels.